文献速递技术与安全MR

钆哌醇:一种兼具高稳定性和高弛豫率的q=2钆基MRI对比剂

Gadopiclenol: A q = 2 Gadolinium-Based MRI Contrast Agent Combining High Stability and Efficacy.
PubMed 文献 · Invest Radiol · 2024-10-09

钆哌醇是一种q=2的吡啶并大环钆对比剂,已获美国食品药品监督管理局、欧洲药品管理局等批准。本研究通过体外多种应激条件和大鼠肾脏体内实验证明其稳定性,并显示其弛豫率高于市售传统钆对比剂。

要点

  • 钆哌醇每个钆络合物含2个内界水分子,弛豫率高于q=1的传统大环钆对比剂。
  • 在生理条件及应激条件(离子介质、极端pH、温度)下高弛豫率得以维持。
  • 人血清37°C孵育12天后钆释放低于定量下限0.1 μM,大鼠肾脏反复注射后12个月体内稳定。

核心结论

  • 钆哌醇凭借优化的结构设计,是一种高度稳定且有效的q=2大环钆基MRI对比剂。

研究设计与样本

  • 体外理化表征研究:钆哌醇及其化学前体Pi828-Gd与q=1钆络合物比较,采用发光法测定水合数q、17O NMR测定水停留时间,在60 MHz(1.4 T)不同介质、pH和温度下测定质子弛豫率;动力学惰性在人血清、酸性介质、锌竞争(含磷酸盐)及配体竞争条件下评估;体内稳定性在大鼠肾脏反复注射后12个月评估。

诊断标准与关键数值

  • 两种吡啶衍生物均证实每个钆络合物含2个内界水分子。
  • 在水中的高弛豫率在生理条件下及应激条件(离子介质、极端pH、温度)下得以维持。
  • 在酸性条件下,q=2络合物要么无钆释放,要么释放慢于q=1稳定大环钆对比剂。
  • 人血清37°C孵育12天后钆释放低于定量下限0.1 μM。
  • 大鼠肾脏反复注射后12个月证实钆哌醇体内稳定。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Gadopiclenol is a q = 2 pyclen gadolinium-based contrast agent (GBCA) recently approved by the Food and Drug Administration, European Medicines Agency, and other European countries. The aim of this report is to demonstrate its stability in multiple stressed in vitro conditions and in vivo, in rat kidney, while maintaining its higher relaxivity compared with conventional GBCAs on the market.

MATERIALS AND METHODS: Both gadopiclenol and its chemical precursor Pi828-Gd were characterized and compared with q = 1 gadolinium (Gd) complexes. The number of water molecules coordinated to the Gd (the hydration number, q) was determined by luminescence. 17 O NMR (Nuclear Magnetic Resonance) measurements gave access to the water residence time τ M . These parameters were used for the fitting of the nuclear magnetic relaxation dispersion profiles in water. Proton relaxivities of the complexes were determined in different media at 60 MHz (1.4 T), at different pH and temperature. The kinetic inertness was investigated in human serum, acidic media, under zinc competition in the presence of phosphate, and under ligand competition. The in vivo stability was evaluated in rat kidneys 12 months after repeated injections.

RESULTS: The presence of 2 inner-sphere water molecules per Gd complex was confirmed for both pyclen derivatives. The high relaxivity of the complexes in water is maintained under physiological conditions, even under stressed conditions (ionic media, extreme pH, and temperature), which guarantees their efficiency in a large range of in vivo situations. Gd release from the q = 2 complexes was investigated in different potentially destabilizing conditions. Either no Gd release or a slower one than with "q = 1" stable macrocyclic GBCA (acidic conditions) was observed. Their kinetic inertness was demonstrated in physiological conditions, and the Gd release was below the lower limit of quantification of 0.1 μM after 12 days at 37°C in human serum. It was also demonstrated that gadopiclenol is stable in vivo in rat kidney 12 months after repeated injections.

CONCLUSIONS: Thanks to its optimized structural design, gadopiclenol is a highly stable and effective macrocyclic q = 2 GBCA.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Maimouni I, Henoumont C, De Goltstein MC, et al. Gadopiclenol: A q = 2 Gadolinium-Based MRI Contrast Agent Combining High Stability and Efficacy. Invest Radiol. 2024. PMID: 39724578. doi:10.1097/RLI.0000000000001121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。